From: Application of ATC/DDD methodology to eveluate of antibiotic use in a general hospital in Turkey
Antibiotics | ATC code | Internal medicine units | Surgical units | Intensive care units | Total | Total rate | ||||
---|---|---|---|---|---|---|---|---|---|---|
DDDs | ACI | DDDs | ACI | DDDs | ACI | DDDs | ACI | % | ||
Penicillins | J01CR | 16.9 | 9.3 | 0 | 0 | 0 | 0 | 16.9 | 5.5 | 10 |
First generation cephalosporins | J01DB | 3.3 | 1.8 | 30.7 | 27.2 | 1.3 | 9.3 | 35.3 | 11.5 | 20.8 |
Second generation cephalosporins | J01DC | 23 | 12.7 | 3 | 2.7 | 0 | 0 | 26 | 8.4 | 15.2 |
Third generation cephalosporins | J01DD | 19.8 | 10.9 | 10 | 8.8 | 6 | 42.9 | 35.8 | 11.6 | 21 |
Carbapenems | J01DH | 2.1 | 1.2 | 1 | 0.9 | 2 | 14.3 | 5.1 | 1.7 | 3.1 |
Aminoglycosides | J01GB | 0.8 | 0.4 | 6.7 | 5.9 | 0 | 0 | 7.5 | 2.4 | 4.4 |
Imidazoles | J01XD | 0 | 0 | 3 | 2.7 | 0 | 0 | 3 | 0.9 | 1.7 |
Glycopeptides | J01XA | 3 | 1.7 | 0 | 0 | 1 | 7.1 | 4 | 1.3 | 2.4 |
Fluoroquinolones | J01MA | 22.9 | 12.7 | 1 | 0.9 | 1 | 7.1 | 24.9 | 8.1 | 14.7 |
Others | 10.3 | 5.7 | 0 | 0 | 1 | 7.1 | 11.3 | 3.7 | 6.7 | |
Total | 102.1 | 56.4 | 55.4 | 49.1 | 12.3 | 87.8 | 169.8 | 55.1 | 100 |